Evidence map›Paper›PMID 30669362›Full record

ArticleInternational journal of molecular sciences2019

The Biophysical Interaction of the Danger-Associated Molecular Pattern (DAMP) Calreticulin with the Pattern-Associated Molecular Pattern (PAMP) Lipopolysaccharide.

Unnati M Pandya, Chinaza Egbuta, Trefa M Abdullah Norman, Chih-Yuan Edward Chiang, Valerie R Wiersma, Rekha G Panchal, Edwin Bremer, Paul Eggleton, Leslie I Gold

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Unnati M PandyaNew York University School of Medicine--Langone Health, Departments of Medicine and Pathology, Division of Translational Medicine, 550 First Ave, New York, NY 10016, USA. unnatitauras99@gmail.com.
Chinaza EgbutaNew York University School of Medicine--Langone Health, Departments of Medicine and Pathology, Division of Translational Medicine, 550 First Ave, New York, NY 10016, USA. Chinaza.Egbuta@nyumc.org.
Trefa M Abdullah NormanUniversity of Exeter Medical School, Exeter EX1 2LU, Devon UK. Ta314@exeter.ac.uk.
Chih-Yuan Edward ChiangTarget Discovery and Experimental Microbiology Department, Molecular and Translational Sciences Division, US Army Research Institute of Infectious Diseases, Frederick, MD 21702, USA. chih-yuan.chiang.ctr@mail.mil.
Valerie R WiersmaDepartment of Hematology, University Medical Center Groningen, University of Groningen, 9713GZ Groningen, The Netherlands. v.wiersma@umcg.nl.
Rekha G PanchalTarget Discovery and Experimental Microbiology Department, Molecular and Translational Sciences Division, US Army Research Institute of Infectious Diseases, Frederick, MD 21702, USA. rekha.g.panchal.civ@mail.mil.
Edwin BremerDepartment of Hematology, University Medical Center Groningen, University of Groningen, 9713GZ Groningen, The Netherlands. e.bremer@umcg.nl.
Paul EggletonUniversity of Exeter Medical School, Exeter EX1 2LU, Devon UK. Paul.eggleton@ucb.com.
Leslie I GoldNew York University School of Medicine--Langone Health, Departments of Medicine and Pathology, Division of Translational Medicine, 550 First Ave, New York, NY 10016, USA. leslie.gold@NYUMC.org.
NYU Langone Health · USTarget (United States) · USUCB Pharma (United Kingdom) · GBUnited States Army Medical Research Institute of Infectious Diseases · USUniversity Medical Center Groningen · NLUniversity of Exeter · GBUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endoplasmic reticulum (ER) chaperone protein, calreticulin (CRT), is essential for proper glycoprotein folding and maintaining cellular calcium homeostasis. During ER stress, CRT is overexpressed as part of the unfolded protein response (UPR). In addition, CRT can be released as a damage-associated molecular pattern (DAMP) molecule that may interact with pathogen-associated molecular patterns (PAMPs) during the innate immune response. One such PAMP is lipopolysaccharide (LPS), a component of the gram-negative bacterial cell wall. In this report, we show that recombinant and native human placental CRT strongly interacts with LPS in solution, solid phase, and the surface of gram-negative and gram-positive bacteria. Furthermore, LPS induces oilgomerization of CRT with a disappearance of the monomeric form. The application of recombinant CRT (rCRT) to size exclusion and anion exchange chromatography shows an atypical heterogeneous elution profile, indicating that LPS affects the conformation and ionic charge of CRT. Interestingly, LPS bound to CRT is detected in sera of bronchiectasis patients with chronic bacterial infections. By ELISA, rCRT dose-dependently bound to solid phase LPS via the N- and C-domain globular head region of CRT and the C-domain alone. The specific interaction of CRT with LPS may be important in PAMP innate immunity.

Indexed as

AlarminsAnimalsCalreticulinChromatography, GelEndotoxinsHumansLipopolysaccharidesPolysaccharides, BacterialProtein BindingProtein Interaction Domains and MotifsProtein MultimerizationRecombinant ProteinsAlarminsCalreticulinEndotoxinsLipopolysaccharidesPolysaccharides, BacterialRecombinant Proteinsbacterial opsonincalreticulinDanger Associated Molecular Patterns (DAMPs)endoplasmic reticulum chaperoneinnate immunitylipopolysaccharidePathogen Associated Molecular Patterns (PAMPs)

Identifiers

PMID30669362
PMCPMC6359024
OpenAlexW2910221304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.